<DOC>
	<DOC>NCT00503061</DOC>
	<brief_summary>To investigate how common it is that patients using Symibort SMART take high average daily doses that are not considered appropriate by their physician (overuse) or are hospitalised due to their asthma at least partly due to underuse.</brief_summary>
	<brief_title>A Pharmaceopidemiological Study in Patients Who Use Symbicort SMART</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
	<criteria>Asthma diagnosis, patient registered with the prescribing physician for at least one year before the qualifying prescription of Symbicort, prescription of Symbicort SMART after UK launch of the concept</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>pharmaceopidemiological</keyword>
	<keyword>Symbicort SMART</keyword>
	<keyword>GPRD</keyword>
</DOC>